Title: Eliud Oloo: Innovator in Immunogenic Research
Introduction
Eliud Oloo is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunogenic research, particularly in the development of modified proteins for vaccine applications. His work focuses on addressing invasive pneumococcal diseases caused by Streptococcus pneumoniae.
Latest Patents
Eliud Oloo holds a patent for "Modified Streptococcus Pneumonia Pneumolysin (ply) Polypeptides." This patent relates to modified pneumolysin proteins that lack hemolytic activity and can be utilized as immunogens in vaccine formulations. The modified proteins include amino acid substitutions at threonine 65, glycine 293, and cysteine 428. Although he currently has 0 patents, his research holds promise for future developments in immunology.
Career Highlights
Eliud Oloo is associated with the National Institute of Public Health and the Environment in the Kingdom of the Netherlands. He works under the representation of the Minister of Health, Welfare and Sport. His research is pivotal in the ongoing efforts to combat pneumococcal diseases through innovative vaccine strategies.
Collaborations
Eliud collaborates with esteemed colleagues such as Raymond Oomen and Martina Ochs-Onolemhemhen. Their combined expertise enhances the research efforts in the field of immunogenic compositions.
Conclusion
Eliud Oloo's work in modified pneumolysin proteins represents a significant advancement in vaccine research. His contributions are vital for developing effective immunogenic solutions against invasive pneumococcal diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.